News

Funding rates for HORIZON-JU-SNS-2023

Published on | 3 years ago

Programmes Digital, Industry & Space Digital Europe

The European Commission has issued additional information on the funding rate for 8 call topics within call HORIZON-JU-SNS-2023 that is open for submission until 25 April 2023.

This update is applicable for the following call topics:

The Commission stresses that funding rates in these topics are: 100% for non-for-profit organizations and 90% with respect to for-profit organizations. Unfortunately, the maximum funding rate in the budget table is set to 100%. The Commission asks all for-profit organizations to make a manual calculation and request only 90% of the budget.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1783 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.